CERS

Conviction 47HealthcareScan · Wed, Oct 14, 2026

Cerus Corp (CERS) closed at $2.24 (-1.11%) on Oct 14, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 33, RS Rating 87, -31.9% from its 52-week high, +13.5% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.

CERS$2.24-1.11%

ResistanceSupportVol 14Insider sell

Vol MA14 2.71M

Jul 17Aug 4Aug 21Sep 9Sep 28Oct 14

Cerus CorpSurgical & Medical Instruments & Apparatuswww.cerus.com ↗

Price2.24

Change-1.11%

Gap-1.55%

Rel volume7.96×

Avg volume2.66M

Avg $ vol6.4M

SMA 202.43

SMA 502.55

SMA 2002.44

Price vs 50-12.30%

Price vs 200-8.40%

MA stackmixed

50/200 cross—

Supertrenddown · 2.51

RSI (14)33

MACD hist-0.01

MACD cross—

Stoch %K / %D8 / 12

ADX (14)25

+DI / −DI14 / 28

RSI divergence—

MACD divergence—

ATR %4.36%

ADR %4.03%

52w high3.28

52w low1.40

From 52w high-31.86%

Above 52w low+59.64%

New 52w highNo

SqueezeOff

Bollinger width25.60%

%B0.19

Donchian pos7.14%

Donchian high2.69

Donchian low2.20

AVWAP (52w high)2.62

vs AVWAP high-14.72%

AVWAP (52w low)2.44

vs AVWAP low-8.36%

OBV trendDown

Chaikin MF (20)0.12

Today vs 20d7.96×

Avg vol (14d)2.71M

Avg vol (20d)2.66M

Avg $ vol (20d)6.4M

Market cap450.41M

RS Rating87 / 99

RS 3m (vs SPY)-32.90%

RS 6m (vs SPY)+0.68%

RS line new highNo

Trend template4/8

Technical rank43.4

1 week-2.40%

1 month-10.60%

3 months-30.37%

6 months+10.64%

1 year+43.27%

YTD+13.45%

P/E-28.82

P/B6.43

P/S1.93

P/FCF406.51

EPS-0.0800

Div yield—

ROE-22.32%

ROA-7.62%

Debt/Eq0.31

Current1.83

EV/EBITDA-62.62

Gross margin—

Net margin-6.68%

Rev growth16.13%

EPS growth25.29%

Price target4.50

Target upside101.34%

Analyst ratingBuy

Institutional80.99%

Ent. value454.3M

Revenue57.44M

Net income-2.94M

Gross profit—

Free cash flow1.11M

IndustrySurgical & Medical Instruments & Apparatus

ExchangeNasdaq

Shares out200.37M

Employees345

ListedFri, Jan 31, 1997

Free float178.47M

Float %92.9%

Short interest17.72M

Days to cover10.0d

Short volume47.0%

Squeeze score65 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.01

Last surprise—

Setup gradeC

Conviction47 / 100

Pattern quality—

Tech rank43.4 / 100

Group rank14 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.74

Support2.23

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CERS

All disclosures →

No recent disclosed trades by Congress in CERS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CERS · open-market 3 sells

Insider	Side	Shares	Value	Traded	Filed
Jensen Chrystal Chief Legal Officer · Common Stock · 2026-08-17	Sell	30K	$90K	2026-08-17	2026-08-17
Gregory Dean A. Director · Common Stock · 2026-06-02	Grant	60K	$0	2026-06-02	2026-06-02
Witney Frank Director · Common Stock · 2026-06-02	Grant	60K	$0	2026-06-02	2026-06-02
NACHTSHEIM JAMI K Director · Common Stock · 2026-06-02	Grant	60K	$0	2026-06-02	2026-06-02
Shan Hua Director · Common Stock · 2026-06-02	Grant	60K	$0	2026-06-02	2026-06-02
Lucena Ann Director · Common Stock · 2026-06-02	Grant	60K	$0	2026-06-02	2026-06-02
BJERKHOLT ERIC Director · Common Stock · 2026-06-02	Grant	60K	$0	2026-06-02	2026-06-02
Jayaraman Vivek K Chief Operating Officer · Common Stock · 2026-05-29	Sell	16.67K	$50K	2026-05-29	2026-06-02
Jayaraman Vivek K Chief Operating Officer · Common Stock · 2026-05-01	Sell	16.67K	$50K	2026-05-01	2026-05-05

SEC filings

EDGAR filings in CERS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.